Biogen Inc. (BIIB) has a market capitalization of $26.26B and trades at $178.96. The 52-week range is 110.04-202.41.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of 20.2, Earnings Per Share (EPS) of $8.85, annual revenue of $9.81B.
The stock has a beta of 0.16, operates in the Healthcare sector.
